← Back to headlines
Eli Lilly Acquires Centessa Pharmaceuticals
Eli Lilly (LLY) has announced the acquisition of Centessa Pharmaceuticals, aiming to further develop Orexin Receptor 2 Agonists for its pharmaceutical pipeline.
26 Jun, 08:06 — 26 Jun, 08:06
Sources
Showing 1 of 1 sources
